Michigan

Diplomat Dispensing REVLIMID® for Multiple Myeloma Maintenance Therapy Following Autologous Hematopoietic Stem Cell Transplant (Auto-HSCT)

FLINT, Mich., March 2, 2017 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), is filling prescriptions for REVLIMID® (lenalidomide) for patients with multiple myeloma as maintenance therapy following autologous hematopoietic stem cell…
Continue Reading »